I promise

"I promise, Suzy... Even if it takes the rest of my life." -Nancy G. Brinker, Founder of Susan G. Komen for the Cure

What is TNBC

WHAT IS TRIPLE NEGATIVE BREAST CANCER?

Just in recent years, Triple Negative Breast Cancer (TNBC) has sparked interest in the news where instead of calling the tumor as ER-negative, PR-negative, and HER2-negative; researchers began using the shorthand term, "Triple Negative," dubbed the "new type" of breast cancer. Being Triple Negative, you don't have a targeted therapy and your only treatment option is chemotherapy.

Triple Negative Breast Cancer is seen in about 15% of all breast cancers. TNBC is a very aggressive cancer that tends to strike younger women, pre-menopause, especially among African-American women and women who have BRCA1 mutations. The tumor tends to be fast growing and is less likely to show up on an annual mammogram. TNBC is more likely to metastasis early on; has a high rate of recurrence in the first 2-3 years from diagnosis and has a poorer prognosis than other types of breast cancer due to lack of specific, targeted treatment for TNBC.

Wednesday, January 29, 2020

Komen Survivor Breakfast 2019

Annual Komen of Northwest Ohio Breakfast Toledo, Ohio on September 7, 2019

Amy Thorpe Willey - breast cancer survivor,
former high school classmate and
Board President of Komen of Northwest Ohio

Breast cancer sisters of the Victory Center
Lynette Layman and Melissa

Breast cancer sisters,
Tammy A. and Melissa

Melissa and Mary Westphal,
Executive President of Komen
Northwest Ohio

Thank you Komen for supporting Dr. Tiwari
and his TNBC research here in Toledo!

Chrys Peterson and Melissa

Total Pageviews



"click image to link"